Dermata Therapeutics (DRMA) Interest & Investment Income (2023 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Interest & Investment Income of $78676.0 for Q1 2026, up 117.24% year-over-year from $36216.0 in Q1 2025, and up 104.33% quarter-over-quarter from $38505.0 in Q4 2025.
Dermata Therapeutics (DRMA) Interest & Investment Income (2023 - 2026) Analysis & Trends
Dermata Therapeutics' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $78676.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 117.24% year-over-year to $78676.0; the TTM figure through Mar 2026 stood at $257501.0 (up 33.63% YoY), while the FY2025 annual figure was $215041.0, down 4.76% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $78676.0, up from $38505.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $92767.0 in Q3 2023, with the low at $31050.0 in Q2 2023.
- The 4-year median for Interest & Investment Income is $54636.0 (2024), against an average of $58978.0.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income plunged 47.74% in 2025, then jumped 117.24% in 2026.
- Dermata Therapeutics' Interest & Investment Income stood at $85859.0 in 2023, then tumbled by 42.52% to $49350.0 in 2024, then fell by 21.98% to $38505.0 in 2025, then soared by 104.33% to $78676.0 in 2026.
- Business Quant data shows DRMA's Interest & Investment Income at $78676.0 in Q1 2026, $38505.0 in Q4 2025, and $68682.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Dermata Therapeutics | 5.40 Mn | 5.40 Mn | - | 78,676.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,676.00 |
| Dec 31, 2025 | 38,505.00 |
| Sep 30, 2025 | 68,682.00 |
| Jun 30, 2025 | 71,638.00 |
| Mar 31, 2025 | 36,216.00 |
| Dec 31, 2024 | 49,350.00 |
| Sep 30, 2024 | 52,497.00 |
| Jun 30, 2024 | 54,636.00 |
| Mar 31, 2024 | 69,298.00 |
| Dec 31, 2023 | 85,859.00 |
| Sep 30, 2023 | 92,767.00 |
| Jun 30, 2023 | 31,050.00 |
| Mar 31, 2023 | 37,540.00 |